# Lamivudine and Zidovudine

NDC: 65862-036
Generic name: Lamivudine and Zidovudine
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170505

FDA application: ANDA077558

## Active ingredients

- LAMIVUDINE: 150 mg/1
- ZIDOVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-036"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-036
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d40292ff-046c-4a04-b801-10768667951a